IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than
A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a pain
Cansativa won the sole contract to distribute homegrown medical cannabis to the domestic market but will the move towards adult-use
Precision-fermented cannabinoids are likely to disrupt Europe’s emerging medicinal and recreational cannabis-farming industry over the next few years – and
BEING the richest country in the world seems to have some inherent advantages. For Luxembourg has just spent €3m on
COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach
UK-based Cannabis start-up AltoVerde is aiming to not only take on the industry big guns but to de-stigmatise and promote
UK-based start-up Panacea Farm is confident it will find a ready market for its North Macedonian cultivated cannabis as the
Berlin headquartered Sanity Group is not only beloved of celebrities but recently completed the biggest ever European Series A funding
GERMANY’s sole domestic cannabis producer is expected to harvest its first crop in early 2022 after securing additional investment to
LYPHE Group, the UK’s leading provider of medical cannabis, has announced a new Medical Advisory Board (MAB) that is set
By Carl Haffner Co-founder and Chief Operations Officer, of UK firm Avida Global Ltd and Chief Executive Officer, Avida Global
LEADING UK business Prohibition Holdings – parent company of global data and canna-tech firm Prohibition Partners – has acquired North
ONE of the UK’s fastest growing and largest cannabis companies has launched its first European operation with more to follow
DESPITE a decline in cannabis flower imports for the first quarter of 2021 the German medical cannabis market continues to
THE medical profession must learn from the way Covid-19 vaccines have been subjected to real-world efficacy trials – and adopt
THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move
We won’t spam you
